180 related articles for article (PubMed ID: 20537188)
21. Genome wide profiling in oral squamous cell carcinoma identifies a four genetic marker signature of prognostic significance.
Vincent-Chong VK; Salahshourifar I; Woo KM; Anwar A; Razali R; Gudimella R; Rahman ZA; Ismail SM; Kallarakkal TG; Ramanathan A; Wan Mustafa WM; Abraham MT; Tay KK; Zain RB
PLoS One; 2017; 12(4):e0174865. PubMed ID: 28384287
[TBL] [Abstract][Full Text] [Related]
22. Tumor-specific genetic expression profile of metastatic oral squamous cell carcinoma.
Méndez E; Fan W; Choi P; Agoff SN; Whipple M; Farwell DG; Futran ND; Weymuller EA; Zhao LP; Chen C
Head Neck; 2007 Sep; 29(9):803-14. PubMed ID: 17573689
[TBL] [Abstract][Full Text] [Related]
23. A 13-gene signature prognostic of HPV-negative OSCC: discovery and external validation.
Lohavanichbutr P; Méndez E; Holsinger FC; Rue TC; Zhang Y; Houck J; Upton MP; Futran N; Schwartz SM; Wang P; Chen C
Clin Cancer Res; 2013 Mar; 19(5):1197-203. PubMed ID: 23319825
[TBL] [Abstract][Full Text] [Related]
24. Identification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinoma.
Yang Z; Liang X; Fu Y; Liu Y; Zheng L; Liu F; Li T; Yin X; Qiao X; Xu X
EBioMedicine; 2019 Sep; 47():44-57. PubMed ID: 31409573
[TBL] [Abstract][Full Text] [Related]
25. Copy Number Alterations Predict Development of OSCC from Oral Leukoplakia.
Cai X; Zhang J; Li L; Liu L; Tang M; Zhou X; Peng C; Li X; Chen X; Xu M; Zhang H; Wang J; Huang Y; Li T
J Dent Res; 2024 Feb; 103(2):138-146. PubMed ID: 38217281
[TBL] [Abstract][Full Text] [Related]
26. Construction of prognostic risk prediction model of oral squamous cell carcinoma based on co-methylated genes.
Zhu Q; Tian G; Gao J
Int J Mol Med; 2019 Sep; 44(3):787-796. PubMed ID: 31198983
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of PD-L2 expression in patients with oral squamous cell carcinoma-A comparison to the PD-L1 expression profile.
Weber M; Wehrhan F; Baran C; Agaimy A; Büttner-Herold M; Kesting M; Ries J
Cancer Med; 2019 Mar; 8(3):1124-1134. PubMed ID: 30659749
[TBL] [Abstract][Full Text] [Related]
28. Epidermal growth factor receptor gene copy number aberration at the primary tumour is significantly associated with extracapsular spread in oral cancer.
Michikawa C; Uzawa N; Sato H; Ohyama Y; Okada N; Amagasa T
Br J Cancer; 2011 Mar; 104(5):850-5. PubMed ID: 21304522
[TBL] [Abstract][Full Text] [Related]
29. ORAOV1 is amplified in oral squamous cell carcinoma.
Xavier FC; Rodini CO; Paiva KB; Destro MF; Severino P; Moyses RA; ; Tajara EH; Nunes FD
J Oral Pathol Med; 2012 Jan; 41(1):54-60. PubMed ID: 21623924
[TBL] [Abstract][Full Text] [Related]
30. Array-comparative genomic hybridization to detect genomewide changes in microdissected primary and metastatic oral squamous cell carcinomas.
Liu CJ; Lin SC; Chen YJ; Chang KM; Chang KW
Mol Carcinog; 2006 Oct; 45(10):721-31. PubMed ID: 16676365
[TBL] [Abstract][Full Text] [Related]
31. Integrated network analysis and logistic regression modeling identify stage-specific genes in Oral Squamous Cell Carcinoma.
Randhawa V; Acharya V
BMC Med Genomics; 2015 Jul; 8():39. PubMed ID: 26179909
[TBL] [Abstract][Full Text] [Related]
32. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
33. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
[TBL] [Abstract][Full Text] [Related]
34. The role of p300 in the tumor progression of oral squamous cell carcinoma.
Cho YA; Hong JS; Choe EJ; Yoon HJ; Hong SD; Lee JI; Hong SP
J Oral Pathol Med; 2015 Mar; 44(3):185-92. PubMed ID: 25154636
[TBL] [Abstract][Full Text] [Related]
35. Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers.
Inchanalkar M; Srivatsa S; Ambatipudi S; Bhosale PG; Patil A; Schäffer AA; Beerenwinkel N; Mahimkar MB
Clin Epigenetics; 2023 May; 15(1):93. PubMed ID: 37245006
[TBL] [Abstract][Full Text] [Related]
36. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
[TBL] [Abstract][Full Text] [Related]
37. Increased placenta growth factor mRNA level is significantly associated with progression, recurrence and poor prognosis of oral squamous cell carcinoma.
Cheng SJ; Cheng SL; Lee JJ; Chen HM; Chang HH; Kok SH; Chiang ML; Kuo MY
J Formos Med Assoc; 2013 May; 112(5):253-8. PubMed ID: 23660220
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of BST2 is associated with nodal metastasis and poorer prognosis in oral cavity cancer.
Fang KH; Kao HK; Chi LM; Liang Y; Liu SC; Hseuh C; Liao CT; Yen TC; Yu JS; Chang KP
Laryngoscope; 2014 Sep; 124(9):E354-60. PubMed ID: 24706327
[TBL] [Abstract][Full Text] [Related]
39. Caveolin-1 Expression at Metastatic Lymph Nodes Predicts Unfavorable Outcome in Patients with Oral Squamous Cell Carcinoma.
Kato K; Miyazawa H; Kobayashi H; Noguchi N; Lambert D; Kawashiri S
Pathol Oncol Res; 2020 Oct; 26(4):2105-2113. PubMed ID: 31907776
[TBL] [Abstract][Full Text] [Related]
40. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]